Acadian Asset Management LLC raised its position in LifeVantage Corp (NASDAQ:LFVN) by 190.9% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 291,624 shares of the company’s stock after acquiring an additional 191,382 shares during the quarter. Acadian Asset Management LLC owned approximately 2.07% of LifeVantage worth $3,204,000 as of its most recent SEC filing.
Other institutional investors have also recently modified their holdings of the company. Tower Research Capital LLC TRC lifted its stake in LifeVantage by 44.7% in the second quarter. Tower Research Capital LLC TRC now owns 16,467 shares of the company’s stock worth $105,000 after acquiring an additional 5,085 shares during the last quarter. Creative Planning purchased a new position in LifeVantage in the third quarter worth approximately $122,000. First Trust Advisors LP purchased a new position in LifeVantage in the third quarter worth approximately $214,000. Dimensional Fund Advisors LP lifted its stake in LifeVantage by 14.1% in the first quarter. Dimensional Fund Advisors LP now owns 128,172 shares of the company’s stock worth $463,000 after acquiring an additional 15,857 shares during the last quarter. Finally, Manatuck Hill Partners LLC purchased a new position in LifeVantage in the second quarter worth approximately $475,000. Institutional investors own 18.06% of the company’s stock.
Shares of LifeVantage stock opened at $11.85 on Friday. The company has a market capitalization of $168.94 million, a P/E ratio of 23.24 and a beta of 0.86. The company has a quick ratio of 1.16, a current ratio of 1.72 and a debt-to-equity ratio of 0.12. LifeVantage Corp has a 52-week low of $3.20 and a 52-week high of $13.29.
LifeVantage (NASDAQ:LFVN) last issued its quarterly earnings data on Wednesday, August 15th. The company reported $0.20 earnings per share for the quarter, topping the consensus estimate of $0.17 by $0.03. The business had revenue of $54.03 million during the quarter. LifeVantage had a net margin of 2.79% and a return on equity of 35.56%. On average, equities research analysts anticipate that LifeVantage Corp will post 0.56 EPS for the current fiscal year.
LifeVantage Company Profile
LifeVantage Corporation engages in the identification, research, development, and distribution of nutraceutical dietary supplements and skin care products. The company offers Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skin care product; Axio, a line of energy drink mixes; Omega+, a fish oil dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and Vitamin D3; and PhysIQ, a weight management system, as well as Petandim for Dogs, a companion pet supplement formulated to treat oxidative stress in dogs.
Featured Story: What is Compound Interest?
Want to see what other hedge funds are holding LFVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LifeVantage Corp (NASDAQ:LFVN).
Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.